Antazoline

Interesting facts

Exploring N,N-Diethyl-2-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)ethanamine

N,N-Diethyl-2-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)ethanamine, a compound with a fascinating structure, is of considerable interest in the field of medicinal chemistry. This compound is characterized by its complex bicyclic structure, which includes elements typical of quinoline derivatives.

Key Facts:

• Versatility in Applications: This compound has potential applications in the development of pharmaceuticals, particularly in treating neurodegenerative diseases due to its structural properties that may enhance interactions with neurological targets.
• Structure-Activity Relationship (SAR): The unique cyclohepta[b]quinoline ring system may provide insights into the relationship between molecular structure and biological activity. Understanding the SAR can guide modifications that enhance efficacy and reduce side effects.
• Research and Development: Ongoing research in synthetic and medicinal chemistry often focuses on compounds like this to discover novel therapeutic agents. Investigating analogs and derivatives can lead to breakthroughs in new drug development.
• Interesting Functional Groups: The presence of diethylamine and ether functionalities creates potential for diverse interactions, influencing both solubility and reactivity, which are critical in drug design.

This compound exemplifies the intricate balance of molecular complexity and biological relevance, highlighting the importance of structural variety in drug design. As researchers continue to explore compounds like N,N-diethyl-2-(7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolin-11-yloxy)ethanamine, the hope for innovative treatments becomes increasingly tangible.